USFDA accepts for priority review the sNDA for Merck’s Prevymis
FDA also accepts a separate supplemental application to extend prophylaxis with PREVYMIS to 200 days in certain HSCT recipients
FDA also accepts a separate supplemental application to extend prophylaxis with PREVYMIS to 200 days in certain HSCT recipients
The company is proud to be at the forefront of promoting cancer awareness and hopes to make a positive impact on the lives of its employees
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Experts’ conclave to pave holistic approach to cancer management
The WHO has urged China to increase adoption of mRNA vaccines, given their high efficacy against variant strains.
Asthma patients are more likely to have an asthma attack during winter
It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
India's G20 Presidency will focus on three main priorities: Health Emergencies Prevention, Preparedness and Response (One Health & AMR); Access and Availability to Affordable Medical Countermeasures (Vaccines, Therapeutics, and Diagnostics); and Digital Health
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
Subscribe To Our Newsletter & Stay Updated